No Hero Left Untreated Act

Magnetic EEG/EKG-guided resonance therapy has successfully treated more than 400 veterans with post-traumatic stress disorder, traumatic brain injury, military sexual trauma, chronic pain, and opiate addiction.

Recent clinical trials and randomized, placebo-controlled, double-blind studies have produced promising measurable outcomes in the evolution of magnetic EEG/EKG-guided resonance therapy.

These outcomes have resulted in escalating demand from returning warriors and veterans who are seeking access to this treatment.

Congress recognizes the importance of initiating innovative pilot programs that demonstrate the use and effectiveness of new treatment options for post-traumatic stress disorder, traumatic brain injury, military sexual trauma, chronic pain, and opiate addiction.

Pilot program— The Secretary of Veterans Affairs shall carry out a pilot program to provide access to magnetic EEG/EKG-guided resonance therapy to treat larger populations of veterans suffering from post-traumatic stress disorder, traumatic brain injury, military sexual trauma, chronic pain, or opiate addiction.

Locations— The Secretary shall carry out the pilot program under subsection (a) at not more than two facilities of the Department of Veteran Affairs.

Participants— In carrying out the pilot program under subsection (a), the Secretary may not provide access to magnetic EEG/EKG-guided resonance therapy to more than 50 veterans.

Duration— The Secretary shall carry out the pilot program under subsection (a) for a 1-year period.

Report— Not later than 90 days after the date of the termination of the pilot program under subsection (a), the Secretary shall submit to the Committees on Veterans’ Affairs of the House of Representatives and the Senate a report on the pilot program.

No authorization of appropriations— No additional funds are authorized to be appropriated to carry out the requirements of this section. Such requirements shall be carried out using amounts otherwise authorized.